APO Research
Talk to an analyst

APO RESEARCH · REPORT

L-glutamine Oral Powder

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global L-glutamine Oral Powder Market Outlook and Growth Opportunities 2026

29 December 2025197 pages

Choose your research edition.

Industry ResearchL-glutamine Oral Powder Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal L-glutamine Oral Powder Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal L-glutamine Oral Powder Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal L-glutamine Oral Powder Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal L-glutamine Oral Powder Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global L-glutamine Oral Powder market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for L-glutamine Oral Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for L-glutamine Oral Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for L-glutamine Oral Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the L-glutamine Oral Powder market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the L-glutamine Oral Powder market include Emmaus Medical and ANI Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global L-glutamine Oral Powder market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of L-glutamine Oral Powder and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents L-glutamine Oral Powder sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the L-glutamine Oral Powder market size, projected growth trends, production technologies, key applications, and end-use industries.

L-glutamine Oral Powder Segment by Company

Emmaus Medical

ANI Pharmaceuticals

L-glutamine Oral Powder Segment by Type

Original Drug

Generic Drug

L-glutamine Oral Powder Segment by Application

Sickle Cell Disease in Children

Sickle Cell Disease in Adults

L-glutamine Oral Powder Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global L-glutamine Oral Powder status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions L-glutamine Oral Powder market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify L-glutamine Oral Powder significant trends, drivers, influence factors in global and regions.

6. To analyze L-glutamine Oral Powder competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global L-glutamine Oral Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of L-glutamine Oral Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of L-glutamine Oral Powder.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the L-glutamine Oral Powder market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global L-glutamine Oral Powder industry.

Chapter 3: Detailed analysis of L-glutamine Oral Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of L-glutamine Oral Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of L-glutamine Oral Powder in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. L-glutamine Oral Powder Industry Trends Table 2. L-glutamine Oral Powder Industry Drivers Table 3. L-glutamine Oral Powder Industry Opportunities and Challenges Table 4. L-glutamine Oral Powder Industry Restraints Table 5. Global L-glutamine Oral Powder Revenue by Company (US$ Million) & (2021-2026) Table 6. Global L-glutamine Oral Powder Revenue Share by Company (2021-2026) Table 7. Global L-glutamine Oral Powder Sales Volume by Company (Units) & (2021-2026) Table 8. Global L-glutamine Oral Powder Sales Volume Share by Company (2021-2026) Table 9. Global L-glutamine Oral Powder Average Price (US$/Unit) of Company (2021-2026) Table 10. Global L-glutamine Oral Powder Company Ranking, (2024-2026) & (USD Million) Table 11. Global L-glutamine Oral Powder Key Company Manufacturing Base & Headquarters Table 12. Global L-glutamine Oral Powder Company, Product Type & Application Table 13. Global L-glutamine Oral Powder Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global L-glutamine Oral Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Original Drug Table 18. Significant Companies of Generic Drug Table 19. Global L-glutamine Oral Powder Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global L-glutamine Oral Powder Sales Volume by Type (2021-2026) & (Units) Table 21. Global L-glutamine Oral Powder Sales Volume by Type (2027-2032) & (Units) Table 22. Global L-glutamine Oral Powder Sales Volume Share by Type (2021-2026) Table 23. Global L-glutamine Oral Powder Sales Volume Share by Type (2027-2032) Table 24. Global L-glutamine Oral Powder Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global L-glutamine Oral Powder Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global L-glutamine Oral Powder Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global L-glutamine Oral Powder Sales Value Share by Type (2021-2026) Table 28. Global L-glutamine Oral Powder Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Sickle Cell Disease in Children Table 30. Significant Companies of Sickle Cell Disease in Adults Table 31. Global L-glutamine Oral Powder Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global L-glutamine Oral Powder Sales Volume by Application (2021-2026) & (Units) Table 33. Global L-glutamine Oral Powder Sales Volume by Application (2027-2032) & (Units) Table 34. Global L-glutamine Oral Powder Sales Volume Share by Application (2021-2026) Table 35. Global L-glutamine Oral Powder Sales Volume Share by Application (2027-2032) Table 36. Global L-glutamine Oral Powder Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global L-glutamine Oral Powder Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global L-glutamine Oral Powder Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global L-glutamine Oral Powder Sales Value Share by Application (2021-2026) Table 40. Global L-glutamine Oral Powder Sales Value Share by Application (2027-2032) Table 41. Global L-glutamine Oral Powder Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global L-glutamine Oral Powder Sales by Region (2021-2026) & (Units) Table 43. Global L-glutamine Oral Powder Sales Market Share by Region (2021-2026) Table 44. Global L-glutamine Oral Powder Sales by Region (2027-2032) & (Units) Table 45. Global L-glutamine Oral Powder Sales Market Share by Region (2027-2032) Table 46. Global L-glutamine Oral Powder Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global L-glutamine Oral Powder Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global L-glutamine Oral Powder Sales Value Share by Region (2021-2026) Table 49. Global L-glutamine Oral Powder Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global L-glutamine Oral Powder Sales Value Share by Region (2027-2032) Table 51. Global L-glutamine Oral Powder Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global L-glutamine Oral Powder Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global L-glutamine Oral Powder Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Global L-glutamine Oral Powder Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global L-glutamine Oral Powder Sales by Country (2021-2026) & (Units) Table 56. Global L-glutamine Oral Powder Sales Market Share by Country (2021-2026) Table 57. Global L-glutamine Oral Powder Sales by Country (2027-2032) & (Units) Table 58. Global L-glutamine Oral Powder Sales Market Share by Country (2027-2032) Table 59. Global L-glutamine Oral Powder Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global L-glutamine Oral Powder Sales Value Market Share by Country (2021-2026) Table 61. Global L-glutamine Oral Powder Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global L-glutamine Oral Powder Sales Value Market Share by Country (2027-2032) Table 63. Emmaus Medical Company Information Table 64. Emmaus Medical Business Overview Table 65. Emmaus Medical L-glutamine Oral Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Emmaus Medical L-glutamine Oral Powder Product Portfolio Table 67. Emmaus Medical Recent Development Table 68. ANI Pharmaceuticals Company Information Table 69. ANI Pharmaceuticals Business Overview Table 70. ANI Pharmaceuticals L-glutamine Oral Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. ANI Pharmaceuticals L-glutamine Oral Powder Product Portfolio Table 72. ANI Pharmaceuticals Recent Development Table 73. Key Raw Materials Table 74. Raw Materials Key Suppliers Table 75. L-glutamine Oral Powder Distributors List Table 76. L-glutamine Oral Powder Customers List Table 77. Research Programs/Design for This Report Table 78. Authors List of This Report Table 79. Secondary Sources Table 80. Primary Sources List of Figures Figure 1. L-glutamine Oral Powder Product Image Figure 2. Global L-glutamine Oral Powder Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global L-glutamine Oral Powder Sales Value (2021-2032) & (US$ Million) Figure 4. Global L-glutamine Oral Powder Sales (2021-2032) & (Units) Figure 5. Global L-glutamine Oral Powder Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global L-glutamine Oral Powder Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Original Drug Image Figure 10. Generic Drug Image Figure 11. Global L-glutamine Oral Powder Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global L-glutamine Oral Powder Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global L-glutamine Oral Powder Sales Volume Share by Type (2021-2032) Figure 14. Global L-glutamine Oral Powder Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global L-glutamine Oral Powder Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global L-glutamine Oral Powder Sales Value Share by Type (2021-2032) Figure 17. Sickle Cell Disease in Children Image Figure 18. Sickle Cell Disease in Adults Image Figure 19. Global L-glutamine Oral Powder Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global L-glutamine Oral Powder Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global L-glutamine Oral Powder Sales Volume Share by Application (2021-2032) Figure 22. Global L-glutamine Oral Powder Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global L-glutamine Oral Powder Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global L-glutamine Oral Powder Sales Value Share by Application (2021-2032) Figure 25. Global L-glutamine Oral Powder Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 26. Global L-glutamine Oral Powder Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global L-glutamine Oral Powder Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global L-glutamine Oral Powder Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America L-glutamine Oral Powder Sales Value (2021-2032) & (US$ Million) Figure 30. North America L-glutamine Oral Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe L-glutamine Oral Powder Sales Value (2021-2032) & (US$ Million) Figure 32. Europe L-glutamine Oral Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific L-glutamine Oral Powder Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific L-glutamine Oral Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America L-glutamine Oral Powder Sales Value (2021-2032) & (US$ Million) Figure 36. South America L-glutamine Oral Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa L-glutamine Oral Powder Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa L-glutamine Oral Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt L-glutamine Oral Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. L-glutamine Oral Powder Value Chain Figure 124. Manufacturing Cost Structure Figure 125. L-glutamine Oral Powder Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Sickle Cell Disease in Children
  • Sickle Cell Disease in Adults
Companies covered
  • Emmaus Medical
  • ANI Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global L-glutamine Oral Powder Sales Value (2021-2032)
  4. 1.2.2 Global L-glutamine Oral Powder Sales Volume (2021-2032)
  5. 1.2.3 Global L-glutamine Oral Powder Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 L-glutamine Oral Powder Market Dynamics
  1. 2.1 L-glutamine Oral Powder Industry Trends
  2. 2.2 L-glutamine Oral Powder Industry Drivers
  3. 2.3 L-glutamine Oral Powder Industry Opportunities and Challenges
  4. 2.4 L-glutamine Oral Powder Industry Restraints
3 L-glutamine Oral Powder Market by Company
  1. 3.1 Global L-glutamine Oral Powder Company Revenue Ranking in 2025
  2. 3.2 Global L-glutamine Oral Powder Revenue by Company (2021-2026)
  3. 3.3 Global L-glutamine Oral Powder Sales Volume by Company (2021-2026)
  4. 3.4 Global L-glutamine Oral Powder Average Price by Company (2021-2026)
  5. 3.5 Global L-glutamine Oral Powder Company Ranking (2024-2026)
  6. 3.6 Global L-glutamine Oral Powder Company Manufacturing Base and Headquarters
  7. 3.7 Global L-glutamine Oral Powder Company Product Type and Application
  8. 3.8 Global L-glutamine Oral Powder Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global L-glutamine Oral Powder Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 L-glutamine Oral Powder Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 L-glutamine Oral Powder Market by Type
  1. 4.1 L-glutamine Oral Powder Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global L-glutamine Oral Powder Sales Volume by Type
  5. 4.2.1 Global L-glutamine Oral Powder Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global L-glutamine Oral Powder Sales Volume by Type (2021-2032)
  7. 4.2.3 Global L-glutamine Oral Powder Sales Volume Share by Type (2021-2032)
  8. 4.3 Global L-glutamine Oral Powder Sales Value by Type
  9. 4.3.1 Global L-glutamine Oral Powder Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global L-glutamine Oral Powder Sales Value by Type (2021-2032)
  11. 4.3.3 Global L-glutamine Oral Powder Sales Value Share by Type (2021-2032)
5 L-glutamine Oral Powder Market by Application
  1. 5.1 L-glutamine Oral Powder Application Introduction
  2. 5.1.1 Sickle Cell Disease in Children
  3. 5.1.2 Sickle Cell Disease in Adults
  4. 5.2 Global L-glutamine Oral Powder Sales Volume by Application
  5. 5.2.1 Global L-glutamine Oral Powder Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global L-glutamine Oral Powder Sales Volume by Application (2021-2032)
  7. 5.2.3 Global L-glutamine Oral Powder Sales Volume Share by Application (2021-2032)
  8. 5.3 Global L-glutamine Oral Powder Sales Value by Application
  9. 5.3.1 Global L-glutamine Oral Powder Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global L-glutamine Oral Powder Sales Value by Application (2021-2032)
  11. 5.3.3 Global L-glutamine Oral Powder Sales Value Share by Application (2021-2032)
6 L-glutamine Oral Powder Regional Sales and Value Analysis
  1. 6.1 Global L-glutamine Oral Powder Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global L-glutamine Oral Powder Sales by Region (2021-2032)
  3. 6.2.1 Global L-glutamine Oral Powder Sales by Region: 2021-2026
  4. 6.2.2 Global L-glutamine Oral Powder Sales by Region (2027-2032)
  5. 6.3 Global L-glutamine Oral Powder Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global L-glutamine Oral Powder Sales Value by Region (2021-2032)
  7. 6.4.1 Global L-glutamine Oral Powder Sales Value by Region: 2021-2026
  8. 6.4.2 Global L-glutamine Oral Powder Sales Value by Region (2027-2032)
  9. 6.5 Global L-glutamine Oral Powder Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America L-glutamine Oral Powder Sales Value (2021-2032)
  12. 6.6.2 North America L-glutamine Oral Powder Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe L-glutamine Oral Powder Sales Value (2021-2032)
  15. 6.7.2 Europe L-glutamine Oral Powder Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific L-glutamine Oral Powder Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific L-glutamine Oral Powder Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America L-glutamine Oral Powder Sales Value (2021-2032)
  21. 6.9.2 South America L-glutamine Oral Powder Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa L-glutamine Oral Powder Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa L-glutamine Oral Powder Sales Value Share by Country, 2025 VS 2032
7 L-glutamine Oral Powder Country-level Sales and Value Analysis
  1. 7.1 Global L-glutamine Oral Powder Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global L-glutamine Oral Powder Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global L-glutamine Oral Powder Sales by Country (2021-2032)
  4. 7.3.1 Global L-glutamine Oral Powder Sales by Country (2021-2026)
  5. 7.3.2 Global L-glutamine Oral Powder Sales by Country (2027-2032)
  6. 7.4 Global L-glutamine Oral Powder Sales Value by Country (2021-2032)
  7. 7.4.1 Global L-glutamine Oral Powder Sales Value by Country (2021-2026)
  8. 7.4.2 Global L-glutamine Oral Powder Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt L-glutamine Oral Powder Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt L-glutamine Oral Powder Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt L-glutamine Oral Powder Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Emmaus Medical
  2. 8.1.1 Emmaus Medical Company Information
  3. 8.1.2 Emmaus Medical Business Overview
  4. 8.1.3 Emmaus Medical L-glutamine Oral Powder Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Emmaus Medical L-glutamine Oral Powder Product Portfolio
  6. 8.1.5 Emmaus Medical Recent Developments
  7. 8.2 ANI Pharmaceuticals
  8. 8.2.1 ANI Pharmaceuticals Company Information
  9. 8.2.2 ANI Pharmaceuticals Business Overview
  10. 8.2.3 ANI Pharmaceuticals L-glutamine Oral Powder Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ANI Pharmaceuticals L-glutamine Oral Powder Product Portfolio
  12. 8.2.5 ANI Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 L-glutamine Oral Powder Value Chain Analysis
  2. 9.1.1 L-glutamine Oral Powder Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 L-glutamine Oral Powder Sales Mode & Process
  6. 9.2 L-glutamine Oral Powder Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 L-glutamine Oral Powder Distributors
  9. 9.2.3 L-glutamine Oral Powder Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst